APA način citiranja

Honda, Y., Imajo, K., Kato, T., Kessoku, T., Ogawa, Y., Tomeno, W., . . . Nakajima, A. (2016). The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice. PLoS One.

Čikaški stil citiranja

Honda, Yasushi, et al. "The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect On Nonalcoholic Steatohepatitis in Mice." PLoS One 2016.

MLA način citiranja

Honda, Yasushi, et al. "The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect On Nonalcoholic Steatohepatitis in Mice." PLoS One 2016.